Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial

被引：0

作者：

Chloé Laurencin

Noémie Timestit

Ana Marques

Domitille Dilly Duchez

Caroline Giordana

Sara Meoni

Marine Huddlestone

Teodor Danaila

Mathieu Anheim

Hélène Klinger

Tiphaine Vidal

Marion Fatisson

Catherine Caire

Mikail Nourredine

Philippe Boulinguez

Carole Dhelens

Bénédicte Ballanger

Stéphane Prange

Sylvie Bin

Stéphane Thobois

机构：

[1] Pierre Wertheimer Neurological Hospital,Department of Neurology C, Expert Parkinson Centre, Hospices Civils de Lyon

[2] Hôpital Neurologique Pierre Wertheimer,Lyon Neuroscience Research Centre

[3] INSERM,Department of Biostatistics

[4] University of Lyon,Department of Neurology

[5] University Hospital of Lyon,Department of Neurology

[6] Clermont-Ferrand University Hospital,Department of Neurology

[7] University Hospital of Saint-Etienne,Movement Disorders Unit, Department of Neurology

[8] University Hospital of Nice,Department of Neurology

[9] University Hospital of Grenoble,Pharmacotoxicology Laboratory, Department of Clinical Research and Epidemiology

[10] Strasbourg University Hospital,Pharmacy, FRIPHARM

[11] University Hospital of Lyon,Public Health Center, Research and Clinical Epidemiology

[12] Edouard Herriot Hospital,Faculté de Medecine Et de Maieutique Lyon Sud Charles Mérieux

[13] Lyon University Hospital,Institut de Génétique Et de Biologie Moléculaire Et Cellulaire (IGBMC)

[14] University Hospital of Lyon,Centre de Référence Des Maladies Neurogénétiques Rares, Fédération de Médecine Translationnelle de Strasbourg (FMTS)

[15] Marc Jeannerod Cognitive Neuroscience Institute,undefined

[16] Université Claude Bernard Lyon 1,undefined

[17] Université de Lyon,undefined

[18] INSERM-U964/CNRS,undefined

[19] UMR7104/Strasbourg University,undefined

[20] Université de Strasbourg,undefined

来源：

Journal of Neurology | 2023年 / 270卷

关键词：

Clonidine; Noradrenergic system; Parkinson’s disease; Impulse control disorder; QUIP-RS;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：4851 / 4859

页数：8

共 50 条

[1] Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial
Laurencin, Chloe
Timestit, Noemie
Marques, Ana
Duchez, Domitille Dilly
Giordana, Caroline
Meoni, Sara
Huddlestone, Marine
Danaila, Teodor
Anheim, Mathieu
Klinger, Helene
Vidal, Tiphaine
Fatisson, Marion
Caire, Catherine
Nourredine, Mikail
Boulinguez, Philippe
Dhelens, Carole
Ballanger, Benedicte
Prange, Stephane
Bin, Sylvie
Thobois, Stephane
JOURNAL OF NEUROLOGY, 2023, 270 (10) : 4851 - 4859
[2] Efficacy and Safety of Clonidine for the Treatment of Impulse Control Disorder in Parkinson's Disease: A Multicentre, Parallel, Randomised, Double Blind, Phase 2b Clinical Trial
Laurencin, C.
Marques, A.
Duchez, D. Dilly
Giordana, C.
Meoni, S.
Anheim, M.
Boulinguez, P.
Ballanger, B.
Thobois, S.
MOVEMENT DISORDERS, 2023, 38 : S35 - S36
[3] Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial
Lin, Hailong
Huang, Leting
Zhou, Jian
Lin, Kaichun
Wang, Hongjiao
Xue, Xia
Xia, Chan
ARCHIVES OF VIROLOGY, 2016, 161 (11) : 3073 - 3080
[4] Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial
Hailong Lin
Leting Huang
Jian Zhou
Kaichun Lin
Hongjiao Wang
Xia Xue
Chan Xia
Archives of Virology, 2016, 161 : 3073 - 3080
[5] ONGOING CLINICAL TRIAL: A PROSPECTIVE MULTICENTRE, PHASE 2B RANDOMISED, CONTROLLED DOUBLE-BLIND TRIAL TO DETERMINE THE SAFETY AND EFFICACY OF PERISPINAL ETANERCEPT ON QUALITY OF LIFE
Thijs, V.
Bernhardt, J.
Cloud, G.
Churilov, L.
Sprigg, N.
Parsons, B.
Gilchrist, N.
Walker, M.
Bath, P.
INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 27 - 27
[6] Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
Simuni, Tanya
Kieburtz, Karl
Tilley, Barbara
Elm, Jordan J.
Ravina, Bernard
Babcock, Debra
Emborg, Marina
Hauser, Robert
Kamp, Cornelia
Morgan, John C.
Ross, G. Webster
Simon, David K.
Bainbridge, Jacci
Baker, Liana
Bodis-Wollner, Ivan
Boyd, James
Cambi, Franca
Carter, Julie
Chou, Kelvin
Dahodwala, Nabila
Dewey, Richard B., Jr.
Dhall, Rohit
Fang, John
Farrow, Buff
Feigin, Andrew
Glazman, Sofya
Goudreau, John
LeBlanc, Pauline
Lee, Stephen
Leehey, Maureen
Lew, Mark F.
Lowenhaupt, Stephanie
Luo, Sheng
Pahwa, Rajesh
Perez, Adriana
Schneider, Jay
Scott, Burton
Shah, Binit
Shannon, Kathleen M.
Sharma, Saloni
Singer, Carlos
Truong, Daniel
Wagner, Renee
Williams, Karen
Wills, Anne Marie
Wong, Pei Shieen
Zadikoff, Cindy
Zweig, Richard
LANCET NEUROLOGY, 2015, 14 (08): : 795 - 803
[7] A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease
Allez, Matthieu
Sands, Bruce E.
Feagan, Brian G.
D'Haens, Geert
De Hertogh, Gert
Randall, Charles W.
Zou, Bin
Johanns, Jewel
O'Brien, Christopher
Curran, Mark
Rebuck, Rory
Wang, Mei-Lun
Sabins, Nina
Baker, Thomas
Kobayashi, Taku
JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1235 - 1251
[8] Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial
Chinnapongse, Robert
Gullo, Kristen
Nemeth, Paul
Zhang, Yuxin
Griggs, Lynn
MOVEMENT DISORDERS, 2012, 27 (02) : 219 - 226
[9] Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
Brightling, Christopher E.
Chanez, Pascal
Leigh, Richard
O'Byrne, Paul M.
Korn, Stephanie
She, Dewei
May, Richard D.
Streicher, Katie
Ranade, Koustubh
Piper, Edward
LANCET RESPIRATORY MEDICINE, 2015, 3 (09): : 692 - 701
[10] Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
Hauser, Robert A.
Cantillon, Marc
Pourcher, Emmanuelle
Micheli, Federico
Mok, Vincent
Onofrj, Marco
Huyck, Susan
Wolski, Kenneth
LANCET NEUROLOGY, 2011, 10 (03): : 221 - 229

← 1 2 3 4 5 →